1mg single vial
In stock
Purchase & earn 85 points!IGF-1 LR3 is a synthetic analog of insulin-like growth factor-1, modified to extend stability and activity in controlled laboratory research settings. It is commonly studied in experimental models involving receptor interaction and peptide-mediated signaling pathways.
In research environments, IGF-1 LR3 is utilized to examine receptor binding behavior, signaling dynamics, and structure-function relationships under controlled conditions. Its modified structure allows researchers to investigate peptide interaction and pathway activity across extended study periods.
Search available certificates by product, strength, lot number, testing date, and test type.
Organized analytical documentation is accessible through the Swift COA Library.
Account tools keep product browsing, orders, and rewards conveniently organized.
Questions about orders or available documentation can be directed to Swift support.
Eligible purchases can earn points through the Swift member rewards program.
You must be at least 18 years old to access this website or purchase products from Swift Peptides.
RESEARCH USE ONLY: All products offered by Swift Peptides are intended strictly for lawful laboratory research use only. Products are not for human or animal consumption and are not intended for medical, therapeutic, diagnostic, cosmetic, veterinary, or household use.
NO MEDICAL USE: Products sold through this website are not offered as drugs, medicines, dietary supplements, or treatments. Swift Peptides does not provide medical advice, dosing instructions, treatment recommendations, or protocols for human or animal use.
RESPONSIBLE HANDLING: Purchasers are responsible for ensuring that products are handled only by appropriately qualified individuals in suitable research environments and in accordance with applicable laws, regulations, safety procedures, and product labeling.
By continuing, you confirm that you are at least 18 years old, understand these restrictions, and agree to our Terms of Service .